Hubbry Logo
MyofilamentMyofilamentMain
Open search
Myofilament
Community hub
Myofilament
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Myofilament
Myofilament
Myofilament
View on Wikipedia
from Wikipedia
Myofilament
Myofilament
Details
Part ofMyofibril
Identifiers
Latinmyofilamentum
THH2.00.05.0.00006
FMA67897
Anatomical terms of microanatomy

Myofilaments are the three protein filaments of myofibrils in muscle cells. The main proteins involved are myosin, actin, and titin. Myosin and actin are the contractile proteins and titin is an elastic protein. The myofilaments act together in muscle contraction, and in order of size are a thick one of mostly myosin, a thin one of mostly actin, and a very thin one of mostly titin.[1][2]

Types of muscle tissue are striated skeletal muscle and cardiac muscle, obliquely striated muscle (found in some invertebrates), and non-striated smooth muscle.[3] Various arrangements of myofilaments create different muscles. Striated muscle has transverse bands of filaments. In obliquely striated muscle, the filaments are staggered. Smooth muscle has irregular arrangements of filaments.

Structure

[edit]
Muscle fiber showing thick and thin myofilaments of a myofibril.

There are three different types of myofilaments: thick, thin, and elastic filaments.[1]

  • Thick filaments consist primarily of a type of myosin, a motor protein – myosin II. Each thick filament is approximately 15 nm in diameter, and each is made of several hundred molecules of myosin. A myosin molecule is shaped like a golf club, with a tail formed of two intertwined chains and a double globular head projecting from it at an angle. Half of the myosin heads angle to the left and half of them angle to the right, creating an area in the middle of the filament known as the M-region or bare zone.[4]
  • Thin filaments, are 7 nm in diameter, and consist primarily of the protein actin, specifically filamentous F-actin. Each F-actin strand is composed of a string of subunits called globular G-actin. Each G-actin has an active site that can bind to the head of a myosin molecule. Each thin filament also has approximately 40 to 60 molecules of tropomyosin, the protein that blocks the active sites of the thin filaments when the muscle is relaxed. Each tropomyosin molecule has a smaller calcium-binding protein called troponin bound to it. All thin filaments are attached to the Z-line.
  • Elastic filaments, 1 μm in diameter, are made of titin, a large springy protein. They run through the core of each thick filament and anchor it to the Z-line, the end point of a sarcomere.[citation needed] Titin also stabilizes the thick filament, while centering it between the thin filaments. It also aids in preventing overstretching of the thick filament, recoiling like a spring whenever a muscle is stretched.

Function

[edit]
Further information: Muscle cell § Muscle contraction in striated muscle

The protein complex composed of actin and myosin, contractile proteins, is sometimes referred to as actomyosin. In striated skeletal and cardiac muscle, the actin and myosin filaments each have a specific and constant length in the order of a few micrometers, far less than the length of the elongated muscle cell (up to several centimeters in some skeletal muscle cells).[5] The contractile nature of this protein complex is based on the structure of the thick and thin filaments. The thick filament, myosin, has a double-headed structure, with the heads positioned at opposite ends of the molecule. During muscle contraction, the heads of the myosin filaments attach to oppositely oriented thin filaments, actin, and pull them past one another. The action of myosin attachment and actin movement results in sarcomere shortening. Muscle contraction consists of the simultaneous shortening of multiple sarcomeres.[6]

Muscle fiber contraction

[edit]
Main article: Muscle contraction

The axon terminal of a motor neuron releases the neurotransmitter, acetylcholine, which diffuses across the synaptic cleft and binds to the muscle fiber membrane. This depolarizes the muscle fiber membrane, and the impulse travels to the muscle's sarcoplasmic reticulum via the transverse tubules. Calcium ions are then released from the sarcoplasmic reticulum into the sarcoplasm and subsequently bind to troponin. Troponin and the associated tropomyosin undergo a conformational change after calcium binding and expose the myosin binding sites on actin, the thin filament. The filaments of actin and myosin then form linkages. After binding, myosin pulls actin filaments toward each other, or inward. Thus muscle contraction occurs, and the sarcomere shortens as this process takes place.[7]

Muscle fiber relaxation

[edit]

The enzyme acetylcholinesterase breaks down acetylcholine and this ceases muscle fiber stimulation. Active transport moves calcium ions back into the sarcoplasmic reticulum of the muscle fiber. ATP causes the binding between actin and myosin filaments to break. Troponin and tropomyosin revert to their original conformation and thereby block binding sites on the actin filament. The muscle fiber relaxes and the entire sarcomere lengthens. The muscle fiber is now prepared for the next contraction.[8]

Response to exercise

[edit]

The changes that occur to the myofilament in response to exercise have long been a subject of interest to exercise physiologists and the athletes who depend on their research for the most advanced training techniques. Athletes across a spectrum of sporting events are particularly interested to know what type of training protocol will result in maximal force generation from a muscle or set of muscles, so much attention has been given to changes in the myofilament under bouts of chronic and acute forms of exercise.

While the exact mechanism of myofilament alteration in response to exercise is still being studied in mammals, some interesting clues have been revealed in Thoroughbred race horses. Researchers studied the presence of mRNA in skeletal muscle of horses at three distinct times; immediately before training, immediately after training, and four hours after training. They reported statistically significant differences in mRNA for genes specific to production of actin. This study provides evidence of the mechanisms for both immediate and delayed myofilament response to exercise at the molecular level.[9]

More recently, myofilament protein changes have been studied in humans in response to resistance training. Again, researchers are not completely clear about the molecular mechanisms of change, and an alteration of fiber-type composition in the myofilament may not be the answer many athletes have long assumed.[10] This study looked at the muscle specific tension in the quadriceps femoris and vastus lateralis of forty-two young men. Researchers report a 17% increase in specific muscle tension after a period of resistance training, despite a decrease in the presence of MyHC, myosin heavy-chain. This study concludes that there is no clear relationship between fiber-type composition and in vivo muscle tension, nor was there evidence of myofilament packing in the trained muscles.

Research

[edit]

Other promising areas of research that may illumine the exact molecular nature of exercise-induced protein remodeling in muscle may be the study of related proteins involved with cell architecture, such as desmin and dystrophin. These proteins are thought to provide the cellular scaffolding necessary for the actin-myosin complex to undergo contraction. Research on desmin revealed that its presence increased greatly in a test group exposed to resistance training, while there was no evidence of desmin increase with endurance training. According to this study, there was no detectable increase in dystrophin in resistance or endurance training.[11] It may be that exercise-induced myofilament alterations involve more than the contractile proteins actin & myosin.

While the research on muscle fiber remodeling is on-going, there are generally accepted facts about the myofilament from the American College of Sports Medicine.[citation needed] It is thought that an increase in muscle strength is due to an increase in muscle fiber size, not an increase in number of muscle fibers and myofilaments. However, there is some evidence of animal satellite cells differentiating into new muscle fibers and not merely providing a support function to muscle cells.

The weakened contractile function of skeletal muscle is also linked to the state of the myofibrils. Recent studies suggest that these conditions are associated with altered single fiber performance due to decreased expression of myofilament proteins and/or changes in myosin-actin cross-bridge interactions. Furthermore, cellular and myofilament-level adaptations are related to diminished whole muscle and whole body performance.[12]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Myofilament

View on Grokipedia
from Grokipedia
Myofilaments are the essential protein filaments within muscle cells that enable contraction, primarily consisting of thick filaments made of and thin filaments composed of , along with regulatory proteins such as and . These structures form the basis of the , the functional unit of striated muscle, and are arranged in a highly organized lattice to generate force and movement. In all muscle types, myofilaments interact via the sliding filament mechanism, powered by , to shorten muscle fibers and produce locomotion or organ function. In skeletal and cardiac muscle, myofilaments are precisely aligned into repeating sarcomeres, giving these tissues their striated appearance. Thick filaments, approximately 1.6 μm long and centered in the sarcomere's A band, are bundles of about 300 myosin molecules, each featuring two heavy chains forming globular heads that bind actin and four light chains for stability. Thin filaments, around 1 μm long, extend from Z discs at the sarcomere edges into the A band, consisting of double-helical F-actin polymers from G-actin monomers, with tropomyosin coiled around to block myosin-binding sites and troponin complexes that respond to calcium ions. Accessory proteins like titin provide elasticity to maintain sarcomere alignment during repeated contractions, while nebulin helps regulate thin filament length. The function of myofilaments centers on the cross-bridge cycle, where myosin heads attach to , undergo a power to slide thin filaments toward the center, and detach upon ATP binding, resulting in muscle shortening without filament length change. In relaxed states, inhibits this interaction; contraction is initiated when calcium binds , shifting to expose binding sites, a process modulated by neural or hormonal signals. This mechanism generates the force for voluntary movement in and rhythmic pumping in , where myofilaments occupy about 70% of tissue volume and are influenced by post-translational modifications for fine-tuned contractility. In , found in organs like blood vessels and the digestive tract, myofilaments are less organized, lacking distinct sarcomeres and instead forming oblique arrays attached to dense bodies and the . Thick filaments here are shorter and side-polar, with isoforms adapted for slower, sustained contractions, while thin filaments retain cores but rely on different regulatory systems like caldesmon and light chain rather than . This arrangement allows for greater flexibility and force maintenance over time, essential for functions such as and vascular tone.

Composition and Types

Thin Filaments

Thin filaments in striated muscle are primarily composed of filamentous (F-actin), which forms a double-stranded helical , with molecules coiled along the actin strands and the complex attached to the tropomyosin. The complex consists of three subunits: (TnC), which binds calcium ions; (TnI), which inhibits actin-myosin interactions; and (TnT), which anchors the complex to . These components assemble in a 7:1:1 stoichiometric ratio of actin::, enabling the thin filament to serve as a regulatory scaffold for . Structurally, thin filaments measure approximately 1 μm in length and 7-8 nm in diameter in striated muscle, with variations across species and fiber types—such as shorter filaments (~0.94 μm) in frog sartorius muscle compared to longer ones (~1.37 μm) in human pectoralis major. The helical arrangement of F-actin provides flexibility and binding sites for regulatory proteins, while stabilizes the filament and modulates access to actin's myosin-binding sites. Different isoforms of contribute to tissue-specific functions within thin filaments. In , α-skeletal actin predominates, supporting high-force generation, whereas α-cardiac actin is the primary isoform in , with adaptations that enhance responsiveness to varying workloads. These isoforms differ by only a few but influence filament stability and interactions with other proteins, as evidenced by structural studies showing distinct filament conformations. The assembly of thin filaments begins with the polymerization of globular (G-actin) monomers into F-actin. This process involves , where three G-actin monomers form a stable trimer, followed by rapid elongation at the filament's barbed and pointed ends through sequential addition of ATP-bound G-actin subunits. In muscle cells, this is tightly regulated to achieve precise filament lengths, with accessory proteins like leiomodin promoting at the barbed end. TnC within the complex binds calcium ions at specific sites, triggering a conformational change that shifts and exposes actin's binding sites for contraction initiation. In , the giant protein nebulin extends along the thin filament, acting as a stabilizer to maintain consistent lengths and prevent , thereby ensuring uniform function.

Thick Filaments

Thick filaments in are bipolar arrays composed primarily of approximately 300 II molecules, which form the core structure responsible for force generation during contraction. Each II molecule is a hexameric protein consisting of two myosin heavy chains (MHCs) that dimerize to create two globular heads connected to a coiled-coil (rod domain), along with four associated light chains—two essential light chains for structural stability and two regulatory light chains that modulate head function. The heads, known as subfragment 1 (S1), contain critical activity and actin-binding sites that enable interaction with thin filaments, while the tail region, comprising subfragment 2 (S2) and the light meromyosin (LMM) domain, facilitates filament assembly. These filaments measure about 1.6 μm in length and 15 nm in diameter, with a central bare zone free of heads flanked by regions where heads project outward in a helical . Myosin heavy chain isoforms vary across muscle types; for instance, MHC-I predominates in slow-twitch (type I) fibers, conferring slower contraction speeds and greater resistance due to lower activity, whereas MHC-II isoforms (such as IIa and IIx) are expressed in fast-twitch (type II) fibers, enabling faster shortening velocities through higher enzymatic rates. These isoform differences allow muscles to adapt to specific physiological demands, such as endurance versus power output. Assembly of thick filaments begins with the self-assembly of tails, driven by ionic interactions and charge distribution along the LMM domain, resulting in a staggered packing that forms the filament backbone with heads oriented as potential cross-bridges. Structural stability is enhanced by accessory proteins: , a giant elastic protein, spans from the Z-disk to the M-line and provides and passive tension to align and maintain filament integrity, while myomesin cross-links filaments at the M-line to support organized packing. In , II variants (such as SM1 and SM2 isoforms) assemble into thick filaments with a distinct side-polar , lacking the regular helical banding pattern characteristic of striations.

Organization and Assembly

Arrangement in the Sarcomere

The , the fundamental contractile unit of striated muscle, is defined as the segment between two adjacent Z-lines, where thin filaments are anchored at their barbed ends by α-actinin proteins. The A-band spans the full length of the thick filaments and includes regions of overlap with thin filaments, while the I-band consists solely of thin filaments extending from the Z-line toward the A-band. Centrally within the A-band lies the H-zone, a lighter region of bare thick filaments devoid of thin filament overlap, bisected by the M-line, which anchors and centers the thick filaments via proteins such as myomesin. This precise banding pattern arises from the interdigitated arrangement of thick and thin myofilaments, with thin filaments extending from opposite Z-lines to partially overlap the thick filaments in the A-band, facilitating potential sliding interactions. Titin, a giant elastic protein, spans from the Z-line to the M-line, serving as a molecular that maintains myofilament alignment and passively centers thick filaments within the during rest and mechanical stress. By linking these structures, ensures structural integrity and prevents misalignment, contributing to the overall stability of the myofibrillar lattice. In the relaxed state, thin filaments typically extend approximately 1 μm from each Z-line, while lengths in mammalian vary between 2 and 3 μm, influencing the degree of filament overlap and thus the muscle's force-generating capacity through the length-tension relationship. dimensions differ between muscle types; for instance, cardiac sarcomeres feature longer thin filaments, around 1.2 μm, compared to the roughly 1 μm in , adapting to the heart's sustained contractile demands.

Molecular Interactions and Assembly

Myofilaments interact primarily through specific binding sites on and , enabling structural stability and functional coordination within the . monomers in thin filaments expose myosin-binding sites that are sterically blocked by in the resting state, preventing unauthorized interactions with heads from thick filaments; this regulatory mechanism ensures precise control over filament engagement. Myosin-binding protein C (MyBP-C), localized along the thick filament's C-zone, further modulates these interactions by binding both and , influencing the spacing and accessibility of cross-bridge formation sites without directly driving contraction. Assembly of thin filaments is tightly regulated to maintain uniform length, primarily through capping proteins that delimit . CapZ binds to the barbed ends of filaments at the Z-disc, preventing excessive elongation and anchoring them into the structure, while tropomodulin caps the pointed ends to stabilize the filament against . For thick filaments, MyBP-C promotes ordered by reducing the critical concentration for assembly and ensuring proper bipolar filament formation, often in coordination with as a protein. Chaperones such as Unc-45b and assist in folding during assembly, protecting nascent proteins from aggregation and facilitating incorporation into functional thick filaments. Higher-order assembly integrates myofilaments into myofibrils via intermediate filaments and associated proteins. Desmin forms a scaffold around Z-discs, linking adjacent myofibrils and stabilizing the overall lattice, with its interactions enhanced by small heat shock proteins like αB-crystallin to prevent misalignment. During development, sarcomerogenesis begins with the formation of pre-myofibrils—stress fiber-like structures containing non-sarcomeric and —that mature into aligned sarcomeres through progressive addition of regulatory proteins like formins (e.g., FHOD3) for . Disruptions in this process, such as mutations in nebulin or cofilin-2, can lead to , characterized by rod-like aggregates and impaired filament assembly. Thin filament dynamics involve continuous turnover to adapt to mechanical stress, mediated by actin-depolymerizing factor (ADF)/cofilin proteins. Cofilin-2 severs actin filaments preferentially near the pointed ends, promoting and recycling of monomers for repolymerization, which maintains filament length and integrity over time. This process is balanced by , which facilitates monomer addition, ensuring steady-state dynamics without net length changes in mature muscle.

Organization in Smooth Muscle

In smooth muscle, myofilaments are arranged in irregular oblique bundles or lattices, lacking the ordered sarcomeres of striated muscle. Thin filaments anchor to cytoplasmic dense bodies and plasma membrane-associated dense plaques, which act as fixation points similar to Z-discs, allowing force transmission across the cell and to adjacent cells via gap junctions. Thick filaments are shorter (approximately 0.5–1.0 μm) and exhibit side-polar organization, with myosin heads projecting laterally in parallel, enabling sustained tonic contractions. Assembly of these myofilaments occurs through polymerization into long filaments and aggregation into bipolar or side-polar structures, facilitated by of regulatory light chains on , which promotes filament formation and stability. Intermediate filaments, including desmin and , interconnect dense bodies and provide cytoskeletal support, maintaining the oblique lattice during dynamic contractions. Unlike striated muscle, lacks sarcomeric proteins like or nebulin, relying instead on caldesmon and calponin for thin filament regulation during assembly and function. This decentralized organization supports the muscle's adaptability for prolonged force generation in visceral organs.

Mechanisms of Contraction and Relaxation

Sliding Filament Theory

The , proposed independently in two seminal papers published on the same day in 1954, describes as the process by which thin filaments composed primarily of slide past thick filaments made of within the , leading to muscle shortening without any change in the lengths of the individual filaments themselves. This mechanism relies on the of (ATP) to provide the energy for filament movement, enabling the —the fundamental contractile unit of striated muscle—to shorten and generate force. The theory revolutionized understanding of muscle mechanics by integrating structural observations from interference microscopy and early electron micrographs, which revealed the interdigitated arrangement of filaments that allows for this sliding action. Contraction begins with the release of calcium ions from the , which bind to on the thin filaments, inducing a conformational change that shifts away from the myosin-binding sites on and thereby exposing them for interaction. Myosin heads then bind to these exposed sites on , undergo a power powered by to pull the thin filaments toward the center of the , and subsequently release to repeat the cycle, resulting in progressive overlap and sarcomere shortening. This process continues as long as calcium levels remain elevated and ATP is available, producing the overall contractile force observed in muscle fibers. The length-tension relationship is a key prediction of the theory, where maximum isometric tension occurs at an optimal length of approximately 2.2 μm, corresponding to maximal overlap between thick and thin filaments that allows the greatest number of myosin-actin cross-bridges to form. At shorter or longer lengths, tension declines due to reduced filament overlap and fewer possible cross-bridges, as demonstrated in precise measurements on single muscle fibers stretched to various lengths during tetanic . The sliding filament mechanism was verified through electron microscopy, which visualized the sliding of filaments during contraction without length changes, and X-ray patterns that confirmed the of filaments and their relative displacement in active muscle. While the theory primarily applies to striated muscles, exhibits variations, including a "latch state" where is maintained at low ATP consumption through slowly cycling cross-bridges, adapting the basic sliding mechanism to sustained contractions. Early experimental evidence supporting the theory came from studies on frog fibers, where length changes directly correlated with filament sliding and tension output under controlled conditions.

Cross-Bridge Cycling

Cross-bridge cycling refers to the repetitive biochemical process by which cross-bridges interact with filaments to generate force and enable muscle shortening. This cycle, first mathematically modeled by A.F. Huxley in 1957, involves a series of conformational changes in the head powered by . Each complete cycle results in a small displacement of the filament relative to the filament, contributing to the overall sliding mechanism of contraction. The cycle begins with the myosin head in a low-energy configuration, bound to actin in the rigor state following ADP release from the previous cycle. ATP binding to the myosin head induces a conformational change that reduces its affinity for actin, causing detachment. Hydrolysis of ATP to ADP and inorganic phosphate (Pi) then "cocks" the myosin head into a high-energy position, storing potential energy for the subsequent power stroke. This hydrolysis step can be represented as: Myosin-ATP+H2O→Myosin-ADP-Pi\text{Myosin-ATP} + \text{H}_2\text{O} \rightarrow \text{Myosin-ADP-Pi} The cocked myosin head weakly binds to a new actin site nearby. Release of Pi strengthens this binding, transitioning to a strong actin-myosin complex and initiating the power , where the myosin head pivots, pulling the actin filament toward the center of the . ADP is then released, completing the power and returning the myosin to the low-energy rigor configuration, ready for ATP binding to restart the cycle. The full cycle equation summarizes the net reaction as driving force generation: ATP→ADP+Pi+force\text{ATP} \rightarrow \text{ADP} + \text{P}_\text{i} + \text{force} The energy for cross-bridge cycling derives from ATP hydrolysis, which releases approximately 12 kcal/mol under physiological conditions in muscle cells. This energy powers the conformational changes, with the overall thermodynamic efficiency of the process reaching about 50% in skeletal muscle, meaning half of the chemical energy is converted to mechanical work while the rest dissipates as heat. The rate of cycling, typically 0.5-2 cycles per second in slow-twitch muscle fibers, determines contraction velocity; faster rates (5-10 cycles per second or more) in fast-twitch fibers allow quicker shortening but may reduce force per cycle. In the absence of ATP, as occurs post-mortem due to depletion, cross-bridges remain locked in the rigor state, causing muscle stiffness known as rigor mortis. Regulation of the cycle occurs primarily through modulation of transition rates between states. Phosphate release is the rate-limiting step, controlling the overall speed of force generation and attachment of strongly bound cross-bridges. In certain muscles, such as smooth and cardiac types, phosphorylation of regulatory light chains accelerates cross-bridge kinetics by enhancing the rate of ADP release or attachment, thereby increasing contraction without altering maximum force. This fine-tuning allows adaptation to varying physiological demands while maintaining the core ATP-driven cycle.

Relaxation

Muscle relaxation occurs when the stimulus for contraction ceases, leading to a decrease in cytosolic calcium concentration. The actively pumps calcium ions back into its lumen via the Ca²⁺-ATPase () pump, powered by ATP. As calcium dissociates from , the - complex undergoes a conformational change that repositions over the myosin-binding sites on , inhibiting further cross-bridge formation. Existing cross-bridges detach upon ATP binding to , and the elastic elements like facilitate the passive return of thin filaments to their resting positions, allowing the to lengthen and the muscle to relax. This process restores the muscle to its pre-contraction state, ready for subsequent activations.

Regulation and Physiological Roles

Calcium-Mediated Regulation

Calcium-mediated regulation of myofilaments is essential for initiating and terminating muscle contraction in striated muscle. In skeletal muscle, upon excitation, an action potential propagates along the sarcolemma and into the T-tubules, triggering voltage-gated dihydropyridine receptors (DHPRs) in the T-tubule membrane. These DHPRs are physically coupled to ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR), leading to conformational changes in RyRs that open Ca²⁺ release channels and allow rapid efflux of Ca²⁺ from the SR into the cytosol. In cardiac muscle, DHPR activation primarily allows Ca²⁺ influx through L-type channels, which triggers Ca²⁺-induced Ca²⁺ release (CICR) via RyR2 channels in the SR, with DHPR and RyR in proximity but not directly coupled for conformational signaling. The released Ca²⁺ ions bind to the regulatory sites of (TnC), the Ca²⁺-binding subunit of the complex on the thin filaments, with a (K_d) of approximately 10⁻⁵ M for these low-affinity sites. This binding induces a conformational change in TnC, which alters the complex such that (TnI) detaches from , relieving its inhibitory effect and allowing to shift position on the filament. Consequently, myosin-binding sites on are exposed, enabling cross-bridge formation and contraction. Myosin-binding protein C (MyBP-C), associated with thick filaments, further modulates this process by influencing cross-bridge kinetics and thin filament Ca²⁺ sensitivity; recent structural analyses (as of 2023) show MyBP-C interacts with heads in relaxed sarcomeres to regulate . Cooperativity in Ca²⁺ binding to TnC enhances the sensitivity of the thin filament to Ca²⁺, allowing for a steep curve that amplifies the contractile response even at submaximal Ca²⁺ levels. In fast-twitch fibers, parvalbumin acts as a cytosolic Ca²⁺ buffer, rapidly binding excess Ca²⁺ post-contraction to facilitate quicker relaxation without interfering with the initial phase. Within the SR, calsequestrin serves as the primary Ca²⁺ storage protein, binding up to 40-50 Ca²⁺ ions per molecule at high capacity to maintain a large releasable pool while modulating RyR activity. For relaxation, cytosolic Ca²⁺ is actively pumped back into the SR by the sarco/ Ca²⁺-ATPase (), primarily the SERCA1 isoform in , which uses to sequester Ca²⁺ against its concentration gradient. As Ca²⁺ dissociates from TnC (with off-rates tuned for rapid deactivation), TnI re-binds to , and repositions to block myosin-binding sites, halting cross-bridge cycling. In , this process is modulated by β-adrenergic signaling, where (PKA) phosphorylates TnI and other myofilament proteins, reducing Ca²⁺ sensitivity to accelerate relaxation and enhance diastolic function.

Adaptations to Exercise and Stress

Endurance training induces adaptive changes in myofilament composition, primarily through shifts in heavy chain (MHC) isoforms toward slower types, enhancing oxidative capacity and fatigue resistance. In models, prolonged exercise (e.g., 60-90 minutes daily for weeks) promotes a fast-to-slow transition, decreasing MHC IIb expression and increasing MHC IIa and I in muscles like the plantaris and soleus, which correlates with improved mitochondrial support for sustained contraction. This isoform shift is mediated by signaling pathways such as AMPK , which upregulates PGC-1α to favor slow-twitch fiber characteristics without necessarily altering overall myofilament density. Recent studies (as of 2025) further indicate that muscle fiber heterogeneity is multi-dimensional, extending beyond MHC isoforms to include variations in metabolic enzymes, ion channels, and structural proteins that contribute to adaptive plasticity. In contrast, resistance training drives myofilament by increasing myofibrillar protein synthesis and myofilament density, leading to greater cross-sectional area and force generation; this process is regulated by signaling, which is acutely activated post-exercise to promote and addition to existing filaments. Under pathological stress like hypoxia or ischemia, myofilaments exhibit functional impairments, including Ca²⁺ desensitization and structural damage, which reduce contractile efficiency. Acute myocardial ischemia decreases myofilament Ca²⁺ sensitivity due to accumulation of inorganic and , impairing cross-bridge formation and force output, while reperfusion exacerbates damage through of thin and thick filament proteins like and . , often accompanying ischemia or chronic conditions, further modifies myofilaments by oxidizing thiol groups on and , forming bonds that depress Ca²⁺ responsiveness and maximal force generation. In aging, cumulative increases stiffness via disulfide crosslinking in its N2B region, contributing to reduced myofilament compliance and passive tension, a key factor in sarcopenic muscle and impaired relaxation. Physiological adaptations also include fiber type transitions influenced by exercise intensity, with endurance promoting fast-to-slow shifts via AMPK-PGC-1α signaling to optimize myofilament efficiency for prolonged activity. Sex differences manifest in baseline myofilament isoform expression, where females typically exhibit a higher proportion of slow MHC I isoforms (up to 20% more Type I fibers), potentially conferring greater but lower peak power compared to males. These adaptations highlight myofilaments' plasticity in balancing force, speed, and under varying demands.

Clinical Significance and Research

Myofilament-related disorders encompass a range of genetic and acquired conditions that impair the structure, function, or calcium sensitivity of myofilaments, leading to , reduced contractility, and potentially life-threatening complications. Genetic myopathies, such as , arise from mutations in genes encoding thin filament proteins like nebulin (NEB) and (TPM), resulting in weakened myofilaments and disrupted actin-myosin interactions that compromise force generation. In (HCM), mutations in the β-myosin heavy chain gene (MYH7) increase myofilament calcium sensitivity, promoting excessive contractility and hypertrophy while altering relaxation dynamics. These genetic defects often manifest early in life and are inherited in autosomal dominant or recessive patterns, highlighting the critical role of myofilament integrity in sarcomeric stability. Acquired disorders further exacerbate myofilament dysfunction through environmental or pathological stressors. In , myofilaments exhibit calcium desensitization, particularly in a frequency-dependent manner due to increased , which reduces force production and impairs diastolic relaxation. induced by extreme exercise causes direct damage to myofibrillar structures, including sarcomeres and myofilaments, leading to muscle breakdown and release of intracellular contents like . Similarly, , often triggered by strenuous exercise in susceptible individuals, provokes uncontrolled calcium release and myofilament hyperactivation, culminating in filament breakdown and systemic . Distinct pathological features characterize these disorders, such as nemaline rods in , which form as aggregates of filaments due to mutant protein instability and altered polymerization. Central core disease, primarily linked to mutations in the ryanodine receptor 1 (RYR1) gene, indirectly disrupts myofilament calcium handling by causing leaky calcium release from the , resulting in core-like regions of depleted myofibrils. typically involves to identify structural abnormalities, genetic sequencing for causative , and functional assays showing reduced myofilament generation, often quantified as decreased calcium sensitivity in skinned fiber preparations. These impairments lead to profound clinical impacts, including progressive , respiratory , and cardiac dysfunction, with early intervention critical for prognosis. Epidemiologically, familial cardiomyopathies like HCM have a prevalence estimated at approximately 1 in 200 to 1 in 500 individuals in the general population, with some recent studies reporting up to 1 in 1000, underscoring their significance as a common genetic heart disorder. Current treatments are largely supportive, but emerging gene therapies show promise; for instance, CRISPR-based approaches targeting titin (TTN) mutations in dilated cardiomyopathy are in preclinical stages, aiming to restore protein expression and myofilament function. Ongoing research emphasizes personalized therapies to mitigate myofilament hypersensitivity or desensitization, potentially improving outcomes in these debilitating conditions.

Advances in Myofilament Research

Since the early 2000s, advances in have revolutionized the understanding of myofilament architecture through high-resolution techniques like cryo-electron microscopy (cryo-EM). Pioneering work on structures, building on foundational biophysical studies of molecular motors, has yielded near-atomic resolution images of cardiac filaments, revealing the folded-back autoinhibited state at 3.6 Å and the super-relaxed state in thick filaments at 6 Å resolution. These structures elucidate how heads interact with regulatory proteins, providing insights into force generation and disease mechanisms. Complementing cryo-EM, has enabled real-time visualization of myofilament dynamics in living cells, such as tracking the of myosin-binding protein C (MyBP-C) during contraction at nanoscale precision, uncovering its role in modulating cross-bridge attachment. Key findings from these techniques highlight MyBP-C's critical function in cardiac contractility, with mutations in its encoding gene (MYBPC3) accounting for 40-50% of (HCM) cases by disrupting regulation and promoting hypercontractility. Optogenetic tools have further advanced the study of calcium-mediated regulation, allowing precise spatiotemporal control of Ca²⁺ influx in cardiomyocytes to probe myofilament responses, such as altering twitch dynamics without electrical pacing. In the , research has emphasized isoform-specific therapeutics, exemplified by , a selective inhibitor of β-cardiac that stabilizes the super-relaxed state to reduce excessive force in obstructive HCM, demonstrating clinical efficacy in reducing left gradients. As of August 2025, the ODYSSEY-HCM showed no significant in peak oxygen uptake for symptomatic nonobstructive HCM, though 2025 real-world data indicate significant reductions in HCM-related hospitalizations and visits. Similarly, AI-driven models, including deep neural networks, now simulate cooperative activation and cross-bridge kinetics in , predicting force-calcium relationships with high fidelity to experimental data. Therapeutic innovations include small molecules like , which sensitizes to calcium in a concentration-dependent manner to enhance contractility in without increasing myocardial oxygen demand. CRISPR-Cas9 editing has enabled targeted correction of myopathy-associated genes in animal models, such as excising intronic sequences in ACTA1 to model and restore organization in and mice. Looking ahead, approaches aim to tailor treatments for fiber-type disproportion myopathies by genotyping-specific interventions to optimize myofiber composition and function. Bioengineered myofilaments, derived from induced pluripotent stem cells, hold promise for regenerative therapies, with constructs exhibiting aligned sarcomeres and contractile responses to electrical stimulation , paving the way for tissue grafts in muscular dystrophies.

References

  1. https://books.byui.edu/bio_461_principles_o/structural_organizat
  2. https://oertx.highered.texas.gov/courseware/lesson/1810/overview
  3. https://www.ncbi.nlm.nih.gov/books/NBK534250/
  4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874884/
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC5658034/
  6. https://books.byui.edu/bio_461_principles_o/smooth_muscle
  7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975104/
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC9140763/
  9. https://www.ncbi.nlm.nih.gov/books/NBK537140/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC3711620/
  11. https://www.ncbi.nlm.nih.gov/books/NBK9961/
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC11796330/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC10072879/
  14. https://www.ncbi.nlm.nih.gov/books/NBK9908/
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC2787778/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC4631897/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC2878950/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC6618170/
  19. https://pubmed.ncbi.nlm.nih.gov/22699393/
  20. https://www.atsjournals.org/doi/full/10.1164/ajrccm.158.supplement_2.13tac400
  21. https://bio.libretexts.org/Bookshelves/Introductory_and_General_Biology/General_Biology_1e_%28OpenStax%29/7%253A_Animal_Structure_and_Function/38%253A_The_Musculoskeletal_System/38.4%253A_Muscle_Contraction_and_Locomotion
  22. https://www.kenhub.com/en/library/anatomy/sarcomere
  23. https://www.physio-pedia.com/Sarcomere
  24. https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/sarcomere
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC9860331/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC6082311/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC2650474/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC12239948/
  29. https://academic.oup.com/cardiovascres/article/77/4/707/337740
  30. https://doi.org/10.1016/j.cell.2021.02.047
  31. https://doi.org/10.1002/cphy.c170023
  32. https://doi.org/10.1083/jcb.128.1.61
  33. https://doi.org/10.1016/j.yjmcc.2020.08.018
  34. https://doi.org/10.3390/ijms21020542
  35. https://doi.org/10.1016/j.devcel.2014.09.002
  36. https://www.ncbi.nlm.nih.gov/books/NBK532857/
  37. https://www.kenhub.com/en/library/anatomy/smooth-musculature
  38. https://courses.lumenlearning.com/suny-ap1/chapter/smooth-muscle/
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC5642817/
  40. https://www.biophysics.org/blog/the-myosin-cross-bridge-cycle
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC4532654/
  42. https://www.sciencedirect.com/science/article/pii/S0079610703001081
  43. https://open.oregonstate.education/anatomy2e/chapter/types-muscle-fibers/
  44. https://www.ncbi.nlm.nih.gov/books/NBK559006/
  45. https://pubs.acs.org/doi/abs/10.1021/bi0260278
  46. https://pubmed.ncbi.nlm.nih.gov/2136951/
  47. https://pubmed.ncbi.nlm.nih.gov/23006480/
  48. https://www.ncbi.nlm.nih.gov/books/NBK538323/
  49. https://pubmed.ncbi.nlm.nih.gov/15709676/
  50. https://pubs.acs.org/doi/10.1021/jp212173f
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC4315934/
  52. https://www.nature.com/articles/s41586-023-06690-5
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC3018540/
  54. https://pubmed.ncbi.nlm.nih.gov/16367751/
  55. https://pubmed.ncbi.nlm.nih.gov/15050380/
  56. https://pmc.ncbi.nlm.nih.gov/articles/PMC8588740/
  57. https://rupress.org/jgp/article/133/6/571/42753/Protein-kinase-A-dependent-modulation-of-Ca2
  58. https://doi.org/10.1152/jappl.1999.86.3.1002
  59. https://pubmed.ncbi.nlm.nih.gov/12813156/
  60. https://www.nature.com/articles/s41467-025-56896-6
  61. https://doi.org/10.2165/00007256-200737020-00004
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC7027239/
  63. https://www.nature.com/articles/s41467-020-16526-9
  64. https://academic.oup.com/hmg/article/21/20/4473/656059
  65. https://pubmed.ncbi.nlm.nih.gov/15550524/
  66. https://journals.physiology.org/doi/full/10.1152/ajpheart.00686.2004
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC6036197/
  68. https://pubmed.ncbi.nlm.nih.gov/17478529/
  69. https://physoc.onlinelibrary.wiley.com/doi/abs/10.1113/jphysiol.2007.134486
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC8549894/
  71. https://www.researchgate.net/publication/16565929_Myofibrillar_Damage_Following_Intense_Eccentric_Exercise_in_Man
  72. https://www.nature.com/articles/s41467-020-18865-z
  73. https://www.researchgate.net/publication/316649345_Strenuous_exercise_triggers_a_life-threatening_response_in_mice_susceptible_to_malignant_hyperthermia
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC1226120/
  75. https://www.sciencedirect.com/science/article/pii/S0167488909001001
  76. https://pubmed.ncbi.nlm.nih.gov/15347586/
  77. https://www.pnas.org/doi/10.1073/pnas.96.7.4164
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC2856782/
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC4911820/
  80. https://www.ahajournals.org/doi/10.1161/circresaha.117.309711
  81. https://www.mayoclinicproceedings.org/article/S0025-6196(23)00457-3/fulltext
  82. https://www.jax.org/news-and-insights/2024/march/crispr-provides-potential-cardiomyopathy-treatment
  83. https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.119.313569
  84. https://www.nature.com/articles/s41467-023-38698-w
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC10846670/
  86. https://rupress.org/jgp/article/153/3/e202012830/211776/In-the-eye-of-the-STORM-Tracking-the-myosin
  87. https://pmc.ncbi.nlm.nih.gov/articles/PMC6660134/
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC5125311/
  89. https://www.science.org/doi/10.1126/sciadv.abo7622
  90. https://www.nejm.org/doi/full/10.1056/NEJMoa2505927
  91. https://www.thecardiologyadvisor.com/reports/mavacamten-results-in-fewer-admissions-ed-visits-in-hypertrophic-cardiomyopathy/
  92. https://pubs.aip.org/aip/aml/article/3/4/046101/3365811/Deep-learning-model-of-myofilament-cooperative
  93. https://pubmed.ncbi.nlm.nih.gov/15628834/
  94. https://skeletalmusclejournal.biomedcentral.com/articles/10.1186/s13395-025-00378-2
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC7709101/
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC7576716/
Add your contribution
Related Hubs
User Avatar
No comments yet.